Suven Pharmaceuticals has informed that it enclosed an invitation for conducting the conference call for investors on Tuesday, February 7, 2023 at 12:00 Noon IST to discuss the Un-Audited Financial Results for the Q3 & 9M FY23, to be declared on February 6, 2023.
The above information is a part of company’s filings submitted to BSE.